These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4363229)

  • 1. Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen.
    Sato Y; Arai H; Suzuki K
    Infect Immun; 1974 May; 9(5):801-10. PubMed ID: 4363229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.
    Morse SI; Morse JH
    J Exp Med; 1976 Jun; 143(6):1483-502. PubMed ID: 58054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.
    Sato Y; Izumiya K; Sato H; Cowell JL; Manclark CR
    Infect Immun; 1981 Mar; 31(3):1223-31. PubMed ID: 6262248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis.
    Arai H; Sato Y
    Biochim Biophys Acta; 1976 Oct; 444(3):765-82. PubMed ID: 186106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The occurrence and properties of leukocytosis and lymphocytosis-stimulating material in the supernatant fluids of Bordetella pertussis cultures.
    Morse SI; Bray KK
    J Exp Med; 1969 Mar; 129(3):523-50. PubMed ID: 4304138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocytosis-promoting factor of Bordetella pertussis. II. Biological properties.
    Sato Y; Arai H; Suzuki K
    Infect Immun; 1973 Jun; 7(6):992-9. PubMed ID: 4351972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.
    Robinson A; Irons LI
    Infect Immun; 1983 May; 40(2):523-8. PubMed ID: 6301999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation and purification of the hemagglutinins from Bordetella pertussis.
    Sato Y; Cowell JL; Sato H; Burstyn DG; Manclark CR
    Infect Immun; 1983 Jul; 41(1):313-20. PubMed ID: 6305841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers.
    Sato Y; Sato H
    Tokai J Exp Clin Med; 1988; 13 Suppl():79-88. PubMed ID: 2908530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic and biochemical properties of the histamine-sensitizing factor from Bordetella pertussis.
    Lehrer SB; Vaughan JH; Tan EM
    J Immunol; 1975 Jan; 114(1 Pt 1):34-9. PubMed ID: 46244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucocytosis-promoting factor of Bordetella pertussis. I. Purification and characterization.
    Sato Y; Arai H
    Infect Immun; 1972 Dec; 6(6):899-904. PubMed ID: 4344632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant of Bordetella pertussis which lacks ability to produce filamentous hemagglutinin.
    Watanabe M; Nakase Y
    Infect Immun; 1982 Mar; 35(3):1018-23. PubMed ID: 6279510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossed immunoelectrophoretic analysis of Bordetella pertussis antigens and of corresponding antibodies in human sera.
    Hertz JB; Hølby N; Andersen V; Baekgaard P
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):386-94. PubMed ID: 187009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigens of Bordetella pertussis. IV. Effect of heat, merthiolate, and formaldehyde on histamine-sensitizing factor and protective activity of soluble extracts from Bordetella pertussi.s.
    Munoz J; Hestekin BM
    J Bacteriol; 1966 Jun; 91(6):2175-9. PubMed ID: 4287581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Properties of an acellular preparation of Bordetella pertussis and its analysis after centrifugation in saccharose gradient].
    Letowska I; Kaczurba E; Schiller B
    Med Dosw Mikrobiol; 1993; 45(3):289-94. PubMed ID: 8189799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Dev Biol Stand; 1991; 73():205-22. PubMed ID: 1778314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of spheroplast-derived strains to differentiate between Bordetella pertussis heat-labile agglutinogens and protective antigen for mice.
    Dolby JM; Bronne-Shanbury CJ
    J Biol Stand; 1975; 3(1):89-100. PubMed ID: 165202
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice of Bordetella pertussis culture fluid, bacterial cells and cell extracts.
    Megret F; Fournier JM; Alouf JE
    Med Microbiol Immunol; 1984; 173(4):225-32. PubMed ID: 6096686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific secondary biological properties of purified rabbit immunoglobulin M and immunoglobulin G antibodies to Brucella abortus and Bordetella pertussis.
    Schulkind ML; Herzberg M; Robbins JB
    Infect Immun; 1971 Sep; 4(3):220-7. PubMed ID: 4343404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.